Open Access

[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression

  • Authors:
    • Chao Cai
    • Huichan He
    • Xiaolu Duan
    • Wenqi Wu
    • Zanlin Mai
    • Tao Zhang
    • Junhong Fan
    • Tuo Deng
    • Wen Zhong
    • Yongda Liu
    • Weide Zhong
    • Guohua Zeng
  • View Affiliations

  • Published online on: February 22, 2023     https://doi.org/10.3892/or.2023.8507
  • Article Number: 70
  • Copyright : © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

April-2023
Volume 49 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cai C, He H, Duan X, Wu W, Mai Z, Zhang T, Fan J, Deng T, Zhong W, Liu Y, Liu Y, et al: [Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression. Oncol Rep 49: 70, 2023
APA
Cai, C., He, H., Duan, X., Wu, W., Mai, Z., Zhang, T. ... Zeng, G. (2023). [Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression. Oncology Reports, 49, 70. https://doi.org/10.3892/or.2023.8507
MLA
Cai, C., He, H., Duan, X., Wu, W., Mai, Z., Zhang, T., Fan, J., Deng, T., Zhong, W., Liu, Y., Zhong, W., Zeng, G."[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression". Oncology Reports 49.4 (2023): 70.
Chicago
Cai, C., He, H., Duan, X., Wu, W., Mai, Z., Zhang, T., Fan, J., Deng, T., Zhong, W., Liu, Y., Zhong, W., Zeng, G."[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression". Oncology Reports 49, no. 4 (2023): 70. https://doi.org/10.3892/or.2023.8507